Interleukin 10 and Dendritic Cells Are the Main Suppression Mediators of Regulatory T Cells in Human Neurocysticercosis
Overview
Authors
Affiliations
Neurocysticercosis is caused by the establishment of Taenia solium cysticerci in the central nervous system. It is considered that, during co-evolution, the parasite developed strategies to modulate the host's immune response. The action mechanisms of regulatory T cells in controlling the immune response in neurocysticercosis are studied in this work. Higher blood levels of regulatory T cells with CD4(+) CD45RO(+) forkhead box protein 3 (FoxP3)(high) and CD4(+) CD25(high) FoxP3(+) CD95(high) phenotype and of non-regulatory CD4(+) CD45RO(+) FoxP3(med) T cells were found in neurocysticercosis patients with respect to controls. Interestingly, regulatory T cells express higher levels of cytotoxic T lymphocyte antigen 4 (CTLA-4), lymphocyte-activation gene 3 (LAG-3), programmed death 1 (PD-1) and glucocorticoid-induced tumour necrosis factor receptor (GITR), suggesting a cell-to-cell contact mechanism with dendritic cells. Furthermore, higher IL-10 and regulatory T cell type 1 (Tr1) levels were found in neurocysticercosis patients' peripheral blood, suggesting that the action mechanism of regulatory T cells involves the release of immunomodulatory cytokines. No evidence was found of the regulatory T cell role in inhibiting the proliferative response. Suppressive regulatory T cells from neurocysticercosis patients correlated negatively with late activated lymphocytes (CD4(+) CD38(+) ). Our results suggest that, during neurocysticercosis, regulatory T cells could control the immune response, probably by a cell-to-cell contact with dendritic cells and interleukin (IL)-10 release by Tr1, to create an immunomodulatory environment that may favour the development of T. solium cysticerci and their permanence in the central nervous system.
Tang N, Schaughency P, Gazzinelli-Guimaraes P, Lack J, Thumm L, Miltenberger E Neurol Neuroimmunol Neuroinflamm. 2024; 11(6):e200320.
PMID: 39475624 PMC: 11527482. DOI: 10.1212/NXI.0000000000200320.
Georgia A, Claudine N, Carole S, Loveline N, Abel L, Flaurent T BMC Immunol. 2024; 25(1):68.
PMID: 39402453 PMC: 11472541. DOI: 10.1186/s12865-024-00654-8.
Arce-Sillas A, Alvarez-Luquin D, Leyva-Hernandez J, Montes-Moratilla E, Vivas-Almazan V, Perez-Correa C J Neural Transm (Vienna). 2024; 131(8):901-916.
PMID: 38822829 DOI: 10.1007/s00702-024-02790-2.
Toledo A, Fragoso G, Carrillo-Mezo R, Romo M, Sciutto E, Fleury A Pathogens. 2023; 12(9).
PMID: 37764924 PMC: 10535301. DOI: 10.3390/pathogens12091116.
Espinosa-Ceron A, Mendez A, Hernandez-Aceves J, Juarez-Gonzalez J, Villalobos N, Hernandez M Brain Sci. 2023; 13(7).
PMID: 37508953 PMC: 10377049. DOI: 10.3390/brainsci13071021.